NEW

GE HealthCare Aims to Advance Women’s Health Imaging

GE HealthCare recently launched the Voluson Signature 20 and 18 ultrasound systems, which comprehensively integrate artificial intelligence (AI), advanced tools and an ergonomic design to speed exam time for clinicians while delivering a clearer picture of various...

FDA Releases Two Companion Reports on Medical Device Safety and Innovation

Today, the U.S. Food and Drug Administration’s (FDA) Center for Devices and Radiological Health Center (CDRH) is releasing two reports on medical device safety and innovation – the core pillars that help protect and promote public health for all. The “CDRH 2024 Safety...

Tri-Imaging, RTI Group Work Together

In a LinkedIn post, Tri-Imaging states, “We are honored to be the first ISO in North America to have the opportunity to try RTI’s new Mako X-Ray Testing Meter. The Mako meter is the most accurate and efficient testing meter that covers the broadest application range...

Detection Technology announces global availability of TFT flat panel detectors

Detection Technology, a global leader in X-ray detector solutions, announces the global availability of a comprehensive range of TFT (thin-film transistor) flat panel detectors. The portfolio includes IGZO (indium gallium zinc oxide) and a-Si (amorphous silicon)...

Flywheel, AIQ Solutions Partner to Improve Understanding of Treatment Response

Flywheel and AIQ Solutions recently announced a partnership to offer a data management and analysis solution to increase clinicians’ and researchers’ understanding of treatment response for complex diseases that include the largest research area of oncology. The combination of Flywheel’s cloud-scale data management and collaboration platform along with the powerful AIQ technology will provide a scalable solution for improved patient management and the overall delivery of accurate data for the therapeutic area.

With Flywheel’s strengths in data ingestion, curation and collaboration and AIQ’s advanced algorithms, physicians and researchers can more quickly determine optimal treatment plans for their patients and ultimately improve patient outcomes.

“Flywheel is excited about the partnership with AIQ as we work together to help clinicians, life sciences companies, and researchers access and share data and analysis that improves the quality and effectiveness of care they can provide to their patients,” says Jim Olson, CEO of Flywheel. “Together, Flywheel and AIQ will offer an integrated technology system unlike anything else available. We look forward to working together to help our customers make better therapy development and patient care decisions,” added Eric Horler, CEO of AIQ.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

Open